Aug 02, 2018 8:00am EDT OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018
Jul 16, 2018 11:57am EDT OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
Jun 11, 2018 8:00am EDT OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
May 18, 2018 9:12am EDT OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
Mar 23, 2018 8:00am EDT OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes